Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
| Image |  |
|---|---|
| Description | scientific article published on 4 April 2017 |
| Author/s |
author: Alain Ravaud Karen Kelly |
| Publication date | April 4, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |